Exclusive: Bitget Wallet adds tokenized U.S. stocks through Reality integration
Source: Investing.com
Bitget Wallet integrated Reality’s tokenized-asset protocol, expanding access to more than 1,700 tokenized stocks and ETFs through its self-custodial wallet. Reality’s rTokens track over 600 U.S. stocks and ETFs with one-to-one backing at Alpaca Securities, daily reserve attestations, exchange-routed liquidity during U.S. market hours, and stablecoin dividend payments. Bitget said its real-world-asset trading volume rose 27% quarter-over-quarter in Q2, highlighting growing demand for tokenized U.S. equity exposure.
Analysis
The economically relevant implication is not incremental equity-volume revenue for NDAQ, but the migration of retail equity exposure into a 24/7, collateralizable wrapper. If tokenized equities gain traction outside U.S. trading hours, brokers, market makers and exchanges could face gradual disintermediation of the customer interface even while regulated venues retain underlying execution and custody economics. The near-term revenue pool is too small to affect NDAQ estimates, but the strategic value of its market-data, execution and surveillance infrastructure rises if it becomes the regulated settlement layer for onchain distribution.
The larger second-order risk sits with retail brokers such as HOOD and IBKR, whose international expansion economics depend on owning the trading relationship, securities lending and cash balances. Tokenized wrappers can compress those monetization pools by turning equity positions into DeFi collateral and paying distributions directly in stablecoins. That said, the model remains vulnerable to regulatory classification, transfer restrictions, sanctions/KYC requirements, and any mismatch between continuous token liquidity and finite underlying-market liquidity; a stress event would likely shift users back toward regulated broker platforms.
Consensus may overstate the immediacy of tokenization as a public-equity catalyst. Broad asset coverage does not establish durable demand, particularly when synthetic or wrapped instruments lack conventional shareholder rights, tax reporting simplicity and institutional settlement finality. The investable signal is an adoption watch: sustained tokenized-equity volumes, bid/ask spreads during U.S. market closures, and evidence that regulated exchanges capture rather than lose execution flows would be required before revising earnings expectations for NDAQ or online brokers.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.35
Ticker Sentiment
Key Decisions for Investors
- No standalone position in APP or SMCI: neither has a direct economic linkage to tokenized-equity adoption, and any read-through from this item would be promotional rather than fundamental.
- Maintain NDAQ as a 6-18 month strategic watch-list long, not an event trade. Upgrade only if disclosures show material tokenized-equity order-routing, data, surveillance or post-trade revenue; falsify the thesis if execution remains predominantly off-exchange/onchain with no regulated-venue volume contribution.
- Monitor HOOD versus NDAQ as a potential 12-month relative-value trade: short HOOD / long NDAQ only if tokenized-equity activity demonstrates persistent non-U.S. retail adoption and stablecoin collateral use. The trade fails if HOOD launches a compliant tokenized-equity product or international net new assets and securities-lending revenue continue accelerating.
- Set a regulatory alert for SEC, FINRA, ESMA and major Asian regulator guidance on tokenized securities custody, investor protections and secondary transferability. Restrictive treatment would favor incumbent broker/exchange infrastructure; permissive cross-border rules would increase competitive pressure on retail brokers.
More News
- Lopsided Tech Bets Get Hit in AI Stock Selloff
- Mizuho reiterates Oracle stock rating on strong results, capacity
- Arrowhead reports phase 1/2a data for dual-gene RNAi therapy
- Etsy stock rises after Oppenheimer upgrade to Outperform
- Lilly to present cardiometabolic drug data at EASD conference
- Evercore ISI adds Aurora Innovation stock ahead of investor day